Skip to main content
Figure 2 | BMC Neuroscience

Figure 2

From: Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models

Figure 2

The effect of Tat-protein (A), Cr (B), GPA (C) or Tat-BCK (D) treatment on uMtCK immunoreactivity in the rat hippocampus. uMtCK immunoreactivity is unaltered after Tat-protein, Cr, GPA or Tat-BCK treatment. Rectangles in panels 1 indicate the regions of panels 2 and 3. Bar = 200 (panel 1) and 25 (panels 2-4) μm.

Back to article page
\